The FDA increased their crackdown on supplements yesterday. About the time that Nulief was launched, the FDA warned that CBD could not be sold in supplements since it was involved in a FDA trial.
My take on all of this is that legal advice was to go completely silent, given that NRTI is a public company.
With the stock nearly worthless, why else would they not make any comment on the issue to shareholders?--what do they have to lose at this point.
In a strange way, I actually feel their silence implies some hope down the road. Mr. James is a respected CFO of Terra Tech, which is rapidly becoming a market leader. The fact that TRTC has made no comment on the partnership indicates that they are biding their time with the FDA and trying not to rock the boat. I believe there is more to this situation than inept and uncaring management.
The situation has been terrible for us investors,
but IMO the FDA situation has a very large role in what has transpired.
News 
Market Data 
Discover 
